JUNB and non-small cell lung carcinoma: Regarding district phenotypes, the predominant phenotype in NSCLC was the (CK+/JUNB+/CXCR4+) in 50% of patients, followed by the (CK+/JUNB+/CXCR4–) in 44%, the (CK+/JUNB–/CXCR4–) in 38% and the (CK+/JUNB–/CXCR4+) in 6% of patients.